[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6689 

# __Potential over-reliance on ai-driven drug discovery__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Balance ai-driven discovery with traditional research methods, encourage diverse research approaches](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8563.md)

## Name of the risk

Reduced diversity in treatment options and potential oversight of non-AI-driven treatment development

## People affected by this risk

* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)

## Stakeholders who can mitigate this risk

* [Healthcare organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_216.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)

## Technologies linked to the risk

* [Ai-powered drug discovery platforms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8137.md)
* [Traditional research methods](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8139.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

